This is what we doClick on the image below for a cartoon presentation of what we do at Chr. Hansen.  |
Working PartnershipWe engage in more than 1,000 development projects with customers each year at Chr. Hansen’s industry technology centers around the globe.  |
Can-do specialistsChr. Hansen is about combining a deep understanding of our customers needs with advanced scientific insight. That is why working for Chr. Hansen is all about sharing and developing your knowledge and passion about what we  |
Social media & Services Announcements, press releases, jobs  Follow us and link up  See and share our videos  Get our press releases in your inbox  News feed of our press releases |
Read our annual report 2010/11 |
Our HistoryClick on the image below for video presentation the Chr. Hansen company history  |
"We experience a very inspiring and fruitful co-operation with Jarrow Formulas," said Brian Peeters, Account Manager from Chr. Hansen, Milwaukee.
The strains GR-1® and RC-14® used in the product are an off-spring of a strategic relationship with Dr Gregor Reid and Dr Andrew Bruce. The famous doctors have isolated and extensively documented these two strains over the last 20 years.
Kaori Dadgostar, PhD, Technical Specialist from Jarrow Formulas says, "The successful launch of Fem-Dophilus® was a joint collaborative effort between Jarrow Formulas, Chr. Hansen, and Drs. Gregor Reid and Andrew Bruce. Jarrow Formulas is honored to have received the NBJ Product Merit Award for Fem-Dophilus®, an oral probiotic supplement, clinically documented to restore and maintain healthy vaginal flora and improve overall urogenital health."
Nominations for the NBJ Business Achievement Awards were screened, reviewed and finally determined by an internal committee of NBJ staff and editorial advisory board members.
* GR-1® and RC-14® are protected by Chr. Hansen A/S and BioGaia AB patent families WO 00/35465 and WO 88/08452, and others.
